BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent - PRNewswire

BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent  PRNewswire

ANN ARBOR, Mich., May 29, 2019 /PRNewswire/ -- BlueWillow Biologics today announced the issuance of U.S. patent number 10,138,279 covering an ...



Comments

Popular posts from this blog

Глушители. Приборы бесшумной стрельбы